Douglas K. Graham retweeted
Dr. Vivien Sheehan led a team of researchers in identifying four genes that expressed more during #SCD pain crises. Their research found that IL-beta was expressed the most, making it the best pain event biomarker for further studies. Learn more: insight.jci.org/articles/vie….
Douglas K. Graham retweeted
For #InternationalWomensDay, we're celebrating all the incredible women that make the Aflac Cancer and Blood Disorders Center such a special place. 💛
Douglas K. Graham retweeted
Our very own @DrEffinger will be on an @USNewsHealth webinar panel on January 26 discussing the state of #cancer care and survivorship, fertility preservation and care coordination for the transition from childhood to adulthood. To register, visit: usnews.com/news/live-events/….
Douglas K. Graham retweeted
Celebrating Dr. Satheesh Chonat for groundbreaking research in @ScienceTM, identifying a potential therapeutic target for acute chest syndrome caused by #SCD. Honored by @EmoryMedicine as this year’s top clinical or translational publication! Read more: bit.ly/4rSIuio.
Douglas K. Graham retweeted
Congrats to Dr. Toby MacDonald who recently published results in @JCI_insight showing anti-brain-tumor responses in a first-in-child trial funded by Peach Bowl LegACy Fund @CFAPeachBowl and @CUREchildcancer. Read the press release: bit.ly/3Yxvl0F.
Douglas K. Graham retweeted
Congrats to Drs. Xu Ji and Sharon Castellino on their newly published study linking survivorship care plans to longer life for childhood cancer survivors. #childhoodcancer
A new study led by researchers at Winship and @childrensatl shows that childhood cancer survivors who engage in long-term survivorship programs and receive a personalized survivorship care plan live longer than those who do not.
Read more ➡️ brnw.ch/21wWI7a
Douglas K. Graham retweeted
Dr. Michelle Schoettler recently published results in @AjHematology showing the new drug Narsoplimab is safe and effective in treating transplant associated thrombotic microangiopathy, a life-threatening complication of #BMT. Learn more: onlinelibrary.wiley.com/doi/….
Douglas K. Graham retweeted
Our researchers recently discovered that targeting the immune system alongside gene therapy may improve outcomes for babies with spinal muscular atrophy, a genetic disorder that weakens motor neurons. Read the study: pnas.org/doi/10.1073/pnas.25….
Douglas K. Graham retweeted
Then vs. Now. From a memorable moment in 1995 to a touching reunion today between @aflac's CEO, Dan Amos and former patient, Elaina, every milestone is a testament to the lives transformed along the way. #pediatriccancer #flashback
Douglas K. Graham retweeted
Congrats to researchers Benjamin Kopp, MD (@KidsLungDoc) and Vivien Sheehan, MD, PhD, on receiving a $3.5 million @NIH grant to study how environmental immune responses predispose kids with sickle cell disease to poor clinical outcomes alongside @EmoryUniversity and @GeorgiaTech.
Douglas K. Graham retweeted
Celebrating our APPs who make a difference every day!👏 Congratulations Caroline Trotter for receiving the 2025 Nursing Excellence Fellowship from @nbd_foundation and Anna Lange for receiving honorable mention for @theSCCH 2025 National Compassionate Caregivers of the Year Award.
Douglas K. Graham retweeted
We recently performed Georgia’s first commercial gene therapy transplant for beta thalassemia. Our teams are working hard to find other avenues for #genetherapy to continue to change the lives of our patients, like Josh. Donate today: give.choa.org/site/Donation2…. #cancerresearch
Douglas K. Graham retweeted
Paul was enrolled in our Peach Bowl, Inc. trial, where after a year of the maintenance drug, Paul was confirmed to have no evidence of disease. Watch Paul's full journey here: youtu.be/7PulyF5QCV0. #ChildhoodCancerAwarenessMonth
Douglas K. Graham retweeted
Dr. Chien and Mikey want you to know that #CapeDayATL is coming October 24! Do you know a kiddo currently battling an illness or injury at Children's or want to honor the strength of a past patient? Purchase a cape to show your support: bit.ly/46sdSdt.
Douglas K. Graham retweeted
Hope in every handprint. 💛🖐️
Thank you, Hyundai @hopeonwheels, for continuing to support our pediatric cancer research and making a mark with this week's Handprint Ceremony for our patients. @BlooperBraves and @GeorgiaTech's mascot, Buzz, joined in on the celebration, too!
Receive a coupon for a free Bundtlet at your next visit when you donate $5 at checkout at participating Georgia bakeries to support the Aflac Cancer and Blood Disorders Center of Children’s during Childhood Cancer Awareness Month!
1
79
Big news for @ATLPedsHemOnc: Georgia’s first gene therapy transplant for beta thalassemia is now a reality.
This breakthrough offers new hope for patients to prevent a lifetime of blood transfusions. Huge thanks to Dr. Jeanne Boudreaux and the entire team. tinyurl.com/mtt286xv
Douglas K. Graham retweeted
Join us in congratulating Dr. Michelle Schoettler on receiving the American Society of Clinical Oncology (@ASCO) Winn Career Development Award! The award will allow collaboration with the National Cancer Institute’s National Clinical Trials Network cooperative groups.
September is Childhood Cancer Awareness Month and Sickle Cell Awareness Month. At @ATLPedsHemOnc, we honor the strength of every child and family facing these diagnoses and remain committed to advancing care, equity, and cures. #ChildhoodCancer #SickleCellAwareness
Douglas K. Graham retweeted
We hope you will join us this September in recognizing Childhood Cancer Awareness Month, a time to honor those with #PediatricCancer. This month, we are extra grateful to the #PedsHemeOnc specialists who work to treat PHO patients and improve outcomes through clinical research.






























